Skip to main content



Medicare Part D Drug Regimen Profiles

This section contains 60 sample drug regimen profiles for comparing the stand alone Medicare Part D prescription drug plans offered in New York State in 2009. Each page contains a list of sample drugs, dosages, typical 30 day supply, and the related indication.

You may search the regimens either by medical indication or by medication. Because there are multiple medications for each regimen and multiple indications for each regimen, you may be directed to the same regimen via multiple links. Each number refers to the same regimen. Click on the number in the right hand column to find the regimen which makes the best match for you.

Each regimen is simply a possible combination of drugs that may be prescribed for the related conditions listed but does not constitute a recommendation of therapy. The regimens presented may differ from your prescribed drugs in many respects but will give a relative idea of the costs for these medications. Compare that cost to the typical retail price to see your potential for savings.

Show Regimens for a(n) Indication Medication



Indication
Regimen
acid reflux 2 7 17 23 34 38 41 55 56
allergies 1
analgesic 4 14 39 44 45 57
angina 10 25 40
anticoagulant 2 15 43 58 59
antifungal 49
antiinflammatory 18 19 22
antinauseant 49
antipsychotic 4 32 42 44 46 50
antithrombotic agent 30
anxiety 39 42 44 47 48 54 56
arrythmias 39 51 60
arthritis 29 30 32 40 43 54 58 59
asthma 1 23 24 55 56
bipolar disorder 44 46
breast cancer 27
cachexia 49
colitis 18
COPD 21 22 29
corticosteroid 23 55
dementia 5 32 33 47 59
depression 5 8 9 10 15 16 18 27 33 38 41 42 44 47 48 50 53 54 56 57 58 59
diabetes 3 6 9 12 16 27 31 45 48 52 57 60
difficulty breathing 7
dyspepsia 49
edema 2 6 10 25 26 36 39 41 46 57
estrogen replacement 12
gastric paresis 41 45
gastritis 5 11 35
GERD 23 29 32
glaucoma 9 12 29 51 58
gout 20 32
heart failure 3 6 10 24 25 26 31 35
high cholesterol 2 3 6 13 17 27 30 31 34 35 36 39 42 45 46 50 58 59 60
HIV/AIDS 49
hormone replacement 53
hypertension 1 2 3 4 5 7 8 11 12 13 14 15 16 18 19 23 24 25 28 30 32 36 39 40 43 45 46 48 50 51 52 57 59 61
immunosuppressant 55
infection 49 53
insomnia 7 12 25 33 40 44 45 50 52 54 57 58 59
low thyroid function 5 13 58 35 53 56
migraines 44
movement disorder 50
neuropathy 43
osteoporosis 4 5 8 27 28 30 33 40 56 57
Parkinson’s disease 47
pepcid ulcer disease 19
peptic ulcer disease 20
peripheral arterial disease 3
peripheral neuropathy 56
potassium replacement 2 10 26 60
prostate cancer 29
prostatic hypertrophy 6 11 37
seasonal rhinitis 46
seizures 8 28 50
thyroid 41 46
tremor 50
urinary retention 38 43
urinary spasms 4 43


This material is based upon work supported by a grant from the Dean of the College of Human Ecology and Smith Lever funds from the Cooperative State Research, Education, and Extension Service, U.S. Department of Agriculture. Any opinions, findings, conclusions, or recommendations expressed in this publication are those of the author(s) and do not necessarily reflect the view of the U.S. Department of Agriculture.